MedTrace Logo

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

NCT00698802 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 397

Last updated 2015-04-14

No results posted yet for this study

Summary

This trial is conducted in Asia and Africa. This trial aims for a comparison of blood glucose control of biphasic human insulin 100 IU/mL and EX1000.

Conditions

Interventions

DRUG

EX1000

Treat-to-target titration scheme, s.c. injection

DRUG

biphasic human insulin

Treat-to-target titration scheme, s.c. injection

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • India
  • South Africa
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00698802 on ClinicalTrials.gov